RAS CORPORATION LIMITED

Company number 13699844 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

RAS CORPORATION LIMITED - Analysis Report

Company Number: 13699844

Analysis Date: 2025-07-29 19:36 UTC

Financial Health Assessment for RAS CORPORATION LIMITED


1. Financial Health Score:

Grade: D (Poor Financial Health)

Explanation:
RAS CORPORATION LIMITED shows significant signs of financial distress, with persistent negative net assets for two out of the three reported years and a worsening liquidity position. The company’s working capital is heavily negative, indicating cash flow constraints and an inability to cover short-term liabilities with current assets, which poses a risk to ongoing operations.


2. Key Vital Signs:

Metric 2023 (£) 2022 (£) 2021 (£) Interpretation
Fixed Assets 1,645 281 281 Small asset base, modest investment in tangible and intangible assets.
Current Assets 8,693 11,724 11,724 Declining current assets, particularly cash reserves, indicating tightening liquidity.
Cash 4,495 11,624 11,624 Significant drop in cash balance, a critical symptom of cash flow stress.
Current Liabilities 24,446 28,409 28,409 High short-term debt obligations relative to assets, increasing pressure on liquidity.
Net Current Assets (Working Capital) -15,753 -16,685 -16,685 Negative working capital shows inability to meet short-term debts with current assets (unhealthy).
Net Assets (Equity) -14,108 16,404 -16,404 Negative net assets in 2023 and 2021 indicate accumulated losses and erosion of shareholder funds.
Shareholders' Funds -14,108 16,404 -16,504 Reflects the same negative trend as net assets, signaling financial distress.

3. Diagnosis:

RAS CORPORATION LIMITED is exhibiting classic symptoms of financial distress. The company’s balance sheet shows a worrying deterioration:

  • Liquidity Crisis: Negative net current assets over multiple years indicate the company does not have enough short-term resources to cover immediate liabilities. This "unhealthy cash flow" situation is a critical red flag and can lead to insolvency if not addressed.
  • Eroding Equity: The sharp drop from positive equity of £16,404 in 2022 to a negative £14,108 in 2023 suggests accumulated losses or write-downs. Negative shareholders' funds reflect "symptoms of distress" and raise concerns regarding solvency and investor confidence.
  • Asset Structure: The company has a very small fixed asset base and modest intangible assets, which may limit its ability to leverage assets for borrowing or sale.
  • Operations: The addition of 4 employees in 2023 suggests expansion efforts, but the financial data does not yet show supporting revenue or profitability improvements.
  • No Audit: The company benefits from small company exemptions and has unaudited abridged accounts, so some financial detail and assurance are lacking, which can create uncertainty.

Overall, the company is in a fragile financial condition, facing liquidity challenges and declining net worth. Immediate attention is required to stabilize finances and avoid potential insolvency risks.


4. Recommendations:

  • Cash Flow Management: Develop a rigorous cash flow forecast and management plan to ensure liquidity. Prioritize collecting receivables and negotiating payment terms with creditors to ease short-term cash pressures.
  • Cost Control: Review operational expenses, particularly staffing and overheads, to align costs with available resources. Avoid unnecessary capital expenditures until cash flow improves.
  • Equity Injection: Consider a capital injection or shareholder loan to shore up net assets and restore solvency. This will provide a financial cushion and improve creditor confidence.
  • Debt Restructuring: Engage with creditors to restructure or extend payment terms of current liabilities. Avoid defaulting to preserve business continuity.
  • Business Review: Evaluate the business model and revenue streams. Identify opportunities for increasing sales or improving margins, especially given the competitive licensed restaurant industry.
  • Professional Advice: Seek external financial and legal advice to explore restructuring options, monitor covenant compliance, and prepare for any potential insolvency scenarios.
  • Transparency: Although audit is not mandatory, improving financial reporting and transparency will help in building trust with banks, investors, and suppliers.

Medical Analogy Summary:

RAS CORPORATION LIMITED’s financial condition resembles a patient with a "weakened heart" due to poor liquidity and "low blood pressure" reflected in negative net assets. Without urgent intervention — akin to administering life-support measures — the company risks "organ failure," or insolvency. Stabilizing cash flow, reducing liabilities, and strengthening equity will help restore this patient to a healthier state.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.